Dr Sam Moxon - Nanomedicine in Dementia Research

Dr Sam Moxon, narrates his blog written for Dementia Researcher.

Nanoparticles are small sized (1-100 nm) particles derived from transition metals, silver, copper, aluminum, silicon, carbon and metal oxides that can easily cross the blood-brain barrier (BBB) and/or produce damage to the barrier integrity by altering endothelial cell membrane permeability. Could this new innovation be the key to targetting new drug therapies to treat Alzheimer's Diseease? Sam explores in this blog for our Tech and Dementia special focus week.

Find the original text, and narration here on our website.

https://www.dementiaresearcher.nihr.ac.uk/guest-blog-techniques-blog-nanomedicine-in-dementia-research/

--

Dr Sam Moxon is a biomaterials scientist at the University of Manchester. His expertise falls on the interface between biology and engineering. His PhD focussed on regenerative medicine and he now works on trying to develop 3D bioprinting techniques with human stem cells, so that we better understand and treat degenerative diseases. Outside of the lab he hikes through the Lake District and is an expert on all things Disney.

Enjoy listening and reading our blogs? We're always on the look out for new contributors, drop us a line and share your own research and careers advice dementiaresearcher@nihr.ac.uk